期刊文献+

CRP、Ps、IL-6与急性冠脉综合征病变及预后相关性研究 被引量:5

Study of the relativity between CRP,Ps,IL-6 and acute coronary syndromes
下载PDF
导出
摘要 目的探讨C-反应蛋白(C-reactive protein,CRP)、P-选择素(P-selectin,Ps)、白细胞介素-6(interleukin-6,IL-6)等炎症标志物与急性冠脉综合征(acute coronary syndrome,ACS)的关系。方法测定126名冠心病患者入院及出院时血中CRP、Ps、IL-6浓度,分析它们与ACS患者病情、冠脉病变程度的关系并观察心脏事件的发生率。结果ACS患者CRP、Ps、IL-6浓度较对照组明显增高(P<0.01),并随病情严重程度增加而增高(急性心肌梗死>不稳定性心绞痛>稳定性心绞痛,P<0.05),也随病变冠脉数量的增加而增高(三支病变组>二支病变组>单支病变组,P<0.05);住院及随访期间发生心脏事件与未发生患者组之间CRP、Ps、IL-6浓度比较,差异均有统计学意义(P<0.01)。结论炎症反应与ACS的发生、发展有关,监测血中CRP、Ps、IL-6等炎症标志物的水平对判断ACS诊断、临床预后评估及中、近期心脏事件发生有较高的预测价值。 [Objective] To study of the relativity between C-reactive protein (CRP), P-selectin (Ps), interleukin- 6 (IL-6) and acute coronary syndrome (ACS). [Methods] The serum CRP, Ps, IL-6 and progression of coronary artery in 126 patients with ACS at hospitalization and discharging were measured, their rate of major adverse cardiac events (MACE) were observed. [Result] The levels of serum CRP, Ps, IL-6 in patients with ACS were significantly higher than normal controls (P 〈0.01), the severer the disease, the higher the levels (stable angina peetoris 〈 unstable angina pectoris 〈 acute myocardial infarction). They also increased with the increasing extent of the numbers of diseased coronary vessels (the 3-vessel-disease group 〉 the 2-vessel-disease group 〉 the 1-vessel- disease group, P 〈0.05), Among them, the levels of serum CRP, Ps and IL-6 in patients with cardiac events were significantly higher than others were in hospital and in following 12 months (P 〈0.01). [Conclusion] Inflammatory reaction was closely associated with ACS, monitoring the levels of CRP, Ps and IL-6 are impoi'tant to diagnosis, treatment, prognosis and anticipant value for shot and long -term cardiac events.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第7期1101-1103,1107,共4页 China Journal of Modern Medicine
关键词 急性冠脉综合征 C-反应蛋白 白细胞介素-6 P-选择素 预后 acute coronary syndrome C-reactive protein intedeukin-6 P-selectin prognosis
  • 相关文献

参考文献8

二级参考文献62

  • 1陈旦红,张黔桓,魏水生,黄平,吴书林,冯建章.老年急性心肌梗死患者中性粒细胞黏附分子的表达和溶栓治疗的影响[J].中华老年医学杂志,2005,24(11):828-830. 被引量:1
  • 2杨功焕,王俊芳,万霞,王黎君,陈爱平.影响中国人群疾病死亡因素的定量分析[J].中华流行病学杂志,2005,26(12):934-938. 被引量:83
  • 3刘勇,闾宏伟,李丽军.高敏C反应蛋白和脂蛋白(a)联合检测在冠心病诊断中的应用[J].中国现代医学杂志,2006,16(6):904-906. 被引量:9
  • 4[1]Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med,1999,340:115-126.
  • 5[2]Anderson J L, Carlquist J F, Joseph B, et al. Evaluation of C-reactive protien, an inflammatory marker, and infectious serology as risk factor for coronary artery disease and myocardial infarction. JACC,1998,32:35-35.
  • 6[3]Haverkate F, Thompson S G, Pyke S D M, et al. Production of C-reactive protien and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet, 1997,349:462-462.
  • 7Yasunobu Y,Hayashi K,Shingu T,et al.Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols.Atherosclerosis,2001,155:445-453.
  • 8Vladimirov E.Free radical lipid peroxidation in biomembrances:mechanism,regulation and biological consequences.In:Johnson JE,eds.Free radical,aging and degeneration disease.New York:Alan R Liss,1986,141-195.
  • 9Palinski W,Yla-Hertuala S,Rosenfeld ME,et al .Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.Arteriosclerosis,1990,10:325-335.
  • 10Kacharava AG,Tertou VV,Orekhov AN.Autoantibodies against low-density lipoprotein and atherogenic potential of blood.Ann Med,1993,25:551-555.

共引文献82

同被引文献67

  • 1徐辉,蔡凯,李介华,夏明凯,黄超龙,张小勇,廖永华.超敏C反应蛋白与血脂联合分析在冠心病中的应用[J].广东医学,2005,26(12):1692-1694. 被引量:5
  • 2MICHAEL B.C-reactive protein:a new risk assessment tool for cardiovascular disease[J].JAOA,2005,105(9):409-416.
  • 3PEARSON T A,MENSAH G A,HONG Y,et al.For the Centers for Disease Control and Prevention and the American Heart Association Workshop on Markers of Inflammation and Cardiovascular Disease.CDC/AHA workshop on markers of inflammation and cardiovascular disease:application to clinical and public health practice:overview[J].Circulation,2004,110(25):e543-544.
  • 4HAGE F G,SZALAI A J.C-reactive protein gene polymorphisms,c-reactive protein blood levels,and cardiovascular disease risk[J].JACC,2007,50(12):1115-1122.
  • 5TENG M S,HSU L A,WU S.Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwan Residents:Interaction with obesity[J].Atherosclerosis,2009,204(2):e64-e69.
  • 6ZEE R Y,HEGENER H H,FERNANDEZ CRUZ A,et al.C-reactive protein gene polymorphisms and the incidence of postangioplasty restenosis[J].Atherosclerosis,2004,176(2):393-396.
  • 7LANGE L A,CARLSON C S,HINDORFF L A,et al.Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events[J].JAMA,2006,296(22):2703-2711.
  • 8SIE M P S,MATTACE RASO F U S,KARDYS I,et al.Genetic variation in the C-reactive protein gene and arterial stiffness:The Rotterdam Study[J].Artery Research,2008,2(4):148-155.
  • 9CRAWFORD D C,SANDERS C L,QIN X,et al.Genetic variation is associated with C-reactive protein levels in the third National Health and Nutrition Examination Survey[J].Circulation,2006,114(23):2458-2465.
  • 10SZALAI A J,WU J,LANGE E M,et al.Single-nucleotidepolymorphismsin the C-reactive protein gene promoter that affect transcription factor binding,alter transcriptional activity,and associate with differences in baseline serum CRP level[J].J Mol Med,2005,83(6):440-447.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部